Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Intertumor heterogeneity of locally advanced gastric cancer.
Authors
Natalia P. Belyak
Saint-Petersburg State University, Medical Faculty, Saint-Petersburg, Russian Federation;
Natalia P. Belyak , Svetlana Kutukova , Rashida Orlova , Ekaterina Kaledina , Alexandra Androsova , Natalia V. Zhukova
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 435)
DOI
10.1200/JCO.2023.41.4_suppl.435
Abstract #
435
Poster Bd #
K1
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Global prevalence of CLDN18.2 in patients with locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Biomarker analysis of two zolbetuximab phase 3 studies (SPOTLIGHT and GLOW).
First Author: Kohei Shitara
Poster
2014 Gastrointestinal Cancers Symposium
A novel method combining gene and protein platforms on one slide for the detection of HER2 in gastric cancer: Final results.
First Author: Dominique Werner
Poster
2012 ASCO Annual Meeting
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.
First Author: Michael Alexander Gordon
Poster
2012 Gastrointestinal Cancers Symposium
Relationship between serum HER2 level and histologic HER2 status in patients with advanced/recurrent gastric cancer.
First Author: Takahide Sasaki